Agreement Establishes a New Stronghold in a Rapidly Expanding Fertility Market

Long-term care facilities play a critical role in caring for the needs of a growing aging population with a lengthening lifespan.

MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced a clinical collaboration to evaluate the safety and efficacy of MEI's ME-401, an investigational PI3K delta inhibitor, in combination with BeiGene's zanubrutinib, an investigational BTK inhibitor, for the treatment of patients with B-cell malignancies.

The Leukemia & Lymphoma Society (LLS) continues to lead cutting-edge research to advance treatments for myeloma and lymphoma. Adding to the momentum, the organization announced a $1,175,000 commitment by the Schwartz Ward Family Foundation (SWFF) of Chicago to support two unique research initiatives including a novel therapy for a rare form of lymphoma and an innovative immunotherapy approach for multiple myeloma.

A genetic counseling group announced earlier this week its support for genetic testing of children during the adoption process.

A study presented at the European Association for the Study of Diabetes found that patients are not storing their insulin at the recommended temperature ranges.

Video and phone sessions can close the gap between academic-based medical settings where cancer patients are more likely to receive genetic counseling and other care settings where they may not, Penn Medicine News reported.

For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack.

The American Brain Tumor Association (ABTA), the nation's first nonprofit organization dedicated to brain tumor education and research, is now accepting Letters of Intent (LOI) for three research funding opportunities.

Reducing prescription drug prices for patients while still encouraging pharmaceutical research and development is a difficult problem to solve politically, the founder of a web-based think tank said in the wake of attack ads against candidates.

New Assays empower Clinicians to more quickly make the right diagnosis at the point-of-care and prescribe the right treatment

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced that it will assume full development and commercial responsibility for its collaboration with Galapagos (Euronext: GLPG) to discover and develop new therapies to treat cystic fibrosis (CF).